Similar articles

• Treatment of Duchenne muscular dystrophy with growth hormone inhibitors.

  Zatz M, Betti RT, Frota-Pessoa O. Zatz M, et al. Am J Med Genet. 1986 Jul;24(3):549-66. doi: 10.1002/ajmg.1320240322. Am J Med Genet. 1986. PMID: 3524231 Clinical Trial.
• Nocturnal rhythm of growth hormone in Duchenne patients: effect of different doses of mazindol and/or cyproheptadine.

  Zatz M, Rapaport D, Pavanello RC, Rocha JM, Vainzof M, Nicolau W. Zatz M, et al. Am J Med Genet. 1989 Aug;33(4):457-67. doi: 10.1002/ajmg.1320330408. Am J Med Genet. 1989. PMID: 2596504
• The effect of mazindol on growth hormone secretion in boys with Duchenne muscular dystrophy.

  Coakley JH, Moorcraft J, Hipkin LJ, Smith CS, Griffiths RD, Edwards RH. Coakley JH, et al. J Neurol Neurosurg Psychiatry. 1988 Dec;51(12):1551-7. doi: 10.1136/jnnp.51.12.1551. J Neurol Neurosurg Psychiatry. 1988. PMID: 3221222 Free PMC article.
• [Treatment problems using anabolic steroids in progressive muscular dystrophy].

  Badalian LO, Temin PA, Mukhin KIu. Badalian LO, et al. Klin Med (Mosk). 1984 Nov;62(11):23-9. Klin Med (Mosk). 1984. PMID: 6394898 Review. Russian. No abstract available.
• Therapeutic trials on progressive muscular dystrophy.

  Satoyoshi E. Satoyoshi E. Intern Med. 1992 Jul;31(7):841-6. doi: 10.2169/internalmedicine.31.841. Intern Med. 1992. PMID: 1450492 Review.